Ovid Therapeutics Stock Alpha and Beta Analysis

OVID Stock  USD 1.05  0.01  0.94%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Ovid Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Ovid Therapeutics over a specified time horizon. Remember, high Ovid Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Ovid Therapeutics' market risk premium analysis include:
Beta
2.34
Alpha
(0.43)
Risk
3.79
Sharpe Ratio
(0.07)
Expected Return
(0.26)
Please note that although Ovid Therapeutics alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Ovid Therapeutics did 0.43  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Ovid Therapeutics stock's relative risk over its benchmark. Ovid Therapeutics has a beta of 2.34  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Ovid Therapeutics will likely underperform. At present, Ovid Therapeutics' Tangible Book Value Per Share is projected to increase slightly based on the last few years of reporting. The current year's Price Book Value Ratio is expected to grow to 3.82, whereas Enterprise Value Multiple is forecasted to decline to (3.87).

Enterprise Value

108.47 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Ovid Therapeutics Backtesting, Ovid Therapeutics Valuation, Ovid Therapeutics Correlation, Ovid Therapeutics Hype Analysis, Ovid Therapeutics Volatility, Ovid Therapeutics History and analyze Ovid Therapeutics Performance.
For information on how to trade Ovid Stock refer to our How to Trade Ovid Stock guide.

Ovid Therapeutics Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Ovid Therapeutics market risk premium is the additional return an investor will receive from holding Ovid Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Ovid Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Ovid Therapeutics' performance over market.
α-0.43   β2.34

Ovid Therapeutics expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Ovid Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Ovid Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Ovid Therapeutics Market Price Analysis

Market price analysis indicators help investors to evaluate how Ovid Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ovid Therapeutics shares will generate the highest return on investment. By understating and applying Ovid Therapeutics stock market price indicators, traders can identify Ovid Therapeutics position entry and exit signals to maximize returns.

Ovid Therapeutics Return and Market Media

The median price of Ovid Therapeutics for the period between Sun, Aug 25, 2024 and Sat, Nov 23, 2024 is 1.15 with a coefficient of variation of 6.29. The daily time series for the period is distributed with a sample standard deviation of 0.07, arithmetic mean of 1.16, and mean deviation of 0.06. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Acquisition by Perone Thomas Michael of 175000 shares of Ovid Therapeutics at 2.72 subject to Rule 16b-3
08/30/2024
2
Disposition of 70000 shares by Alexander Margaret A. of Ovid Therapeutics at 3.73 subject to Rule 16b-3
09/09/2024
3
Meg Alexander Takes on Expanded Role as President and COO at Ovid Therapeutics, Strengthening Leadership for Future Growth - StockTitan
09/11/2024
4
Ovid stock gets boost from promising OV329 toxicity profile - B.Riley - Investing.com
09/27/2024
5
Ovid Therapeutics Inc. Given Consensus Recommendation of Moderate Buy by Analysts
10/11/2024
6
Acquisition by Friedman Bart of 69424 shares of Ovid Therapeutics subject to Rule 16b-3
10/24/2024
7
Acquisition by Williams Douglas E of 13250 shares of Ovid Therapeutics at 5.29 subject to Rule 16b-3
10/25/2024
8
Explainer-How Trumps second administration affects business Musk, tariffs and more
11/06/2024
9
Ovid Therapeutics earnings beat, revenue topped estimates
11/12/2024
10
How controversial is Trumps pick of RFK Jr as US health secretary
11/15/2024
11
B. Riley Predicts Reduced Earnings for Ovid Therapeutics
11/20/2024

About Ovid Therapeutics Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Ovid or other stocks. Alpha measures the amount that position in Ovid Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2023 2024 (projected)
Days Sales Outstanding3.693.28
PTB Ratio2.593.82

Ovid Therapeutics Upcoming Company Events

As portrayed in its financial statements, the presentation of Ovid Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ovid Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Ovid Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Ovid Therapeutics. Please utilize our Beneish M Score to check the likelihood of Ovid Therapeutics' management manipulating its earnings.
11th of March 2024
Upcoming Quarterly Report
View
3rd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
11th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Ovid Therapeutics

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Ovid Therapeutics is a strong investment it is important to analyze Ovid Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ovid Therapeutics' future performance. For an informed investment choice regarding Ovid Stock, refer to the following important reports:
Ovid Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Ovid Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Ovid Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...